“The rollout went well. The first step, and the one that seemed most important, was for caregivers to gain the conviction that these elements and their integration would provide a clinical advantage for patient safety, and this is a particularly important point, as well as for the ergonomics of care.”
Dr. Julien Pottecher,
Head of the Department of Anesthesia-Intensive Care & Perioperative Medicine, Strasbourg University Hospital, France
Common measurement parameters SpO2 - SpHb1 - provides continuous visibility to changes – or lack of changes – in PVi -
SPO2 non-invasive oxygen saturation SpHb non-invasive continuous haemoglobin PVi Pleth Variability index Pi PERF Perfusion index SpOC non-invasive oxygen content SpMet non-invasive methaemoglobin SpCO Carboxyhemoglobin RRa or RRac Acoustic respiration
Horizon trends clearly indicate timely changes in patient condition – to aid you to quickly identify meaningful clinical deviations and take appropriate actions.
Advanced rainbow SET sensors
Philips IntelliVue monitoring platform fits securely into your hospital’s IT environment to capture timely patient data and feed it to the EMR. With more than 1 million monitors sold since 2002, the IntelliVue family of monitoring solutions offers a proven track record for quality.
Reduces unnecessary transfusions
>87% reduction in transfusion frequency (from 4.5% to 0.6%)2 >90% reduction in average units transfused (from 0.1 to 0.01 units per patient)2
Reduces unnecessary transfusions
> 73% to 32% reduction in the percentage of patients receiving 3 or more units3* > 47% reduction in average units transfused (1.9 to 1.0 per patient)3*
Initiate timely transfusions when transfusions are needed
Philips and Masimo have teamed up to create the future of measurements and monitoring.
Masimo clinical claims are referenced on this web page. All studies available at www.masimo.com/evidence/featured-studies/feature/ (1) SpHb** monitoring is not intended to replace lab testing. Blood samples should be analyzed by lab instruments prior to clinical decision making. (2) (3) Awada WN et al J Clin Mon it Comput. DOI 10.1007/s10877-015-9660-4. *Study Protocol: In each group, if researchers noted SpHb trended downward below 10 g/dl, a red blood cell transfusion was started and continued until SpHb trended upward above 10 g/dl. The transfusion threshold of 10 g/dl was predetermined by the study protocol and may not be appropriate for all patients. Blood sampling was the same for the control and test group.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.